- Filed
- May 5, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 18M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $18.41M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $19.82M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $2.54M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $423K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $11.19M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $22.04M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $14M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $13.51M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $33.89M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $35.15M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $32.51M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $36.46M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $40.29M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $44.69M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 17.94M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $86K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$9.04M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $19.99M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $22.69M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.19 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.19 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $10.54M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $1.06M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$3.36M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$3M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $8.6M |
| Revenue | Q1 2025 · Mar 31, 2024 | $14.42M |